BBNX
Beta Bionics, Inc.
Next earnings Jul 27, 2026 · consensus $-0.60 EPS, $32.2M rev
Last earnings -5.0% on 2026-04-21
$14.73
▲ +7.75%$14.73▼ -17.15%
over 1Y
L $8.86EODHDH $31.99
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.8%
1W+11.7%
1M+25.7%
3M+30.2%
YTD-49.6%
1Y-17.2%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 18 analysts
Buy
Revenue grew 53.9% YoY; but unprofitable (net margin -73.0%).
Beta Bionics, Inc. shows $100M in FY2025 revenue (+53.9% YoY), a -73.0% net margin, and -25.5% ROE.
Sources: SEC EDGAR (CIK 0001674632, latest 10-Q filed 2026-04-21) · EODHD · as of 6/22/2026, 11:31:49 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.